Literature DB >> 19921205

Interactive dedicated training curriculum improves accuracy in the interpretation of MR imaging of prostate cancer.

Oguz Akin1, Christopher C Riedl, Nicole M Ishill, Chaya S Moskowitz, Jingbo Zhang, Hedvig Hricak.   

Abstract

OBJECTIVE: To assess the effect of interactive dedicated training on radiology fellows' accuracy in assessing prostate cancer on MRI.
METHODS: Eleven radiology fellows, blinded to clinical and pathological data, independently interpreted preoperative prostate MRI studies, scoring the likelihood of tumour in the peripheral and transition zones and extracapsular extension. Each fellow interpreted 15 studies before dedicated training (to supply baseline interpretation accuracy) and 200 studies (10/week) after attending didactic lectures. Expert radiologists led weekly interactive tutorials comparing fellows' interpretations to pathological tumour maps. To assess interpretation accuracy, receiver operating characteristic (ROC) analysis was conducted, using pathological findings as the reference standard.
RESULTS: In identifying peripheral zone tumour, fellows' average area under the ROC curve (AUC) increased from 0.52 to 0.66 (after didactic lectures; p<0.0001) and remained at 0.66 (end of training; p<0.0001); in the transition zone, their average AUC increased from 0.49 to 0.64 (after didactic lectures; p=0.01) and to 0.68 (end of training; p=0.001). In detecting extracapsular extension, their average AUC increased from 0.50 to 0.67 (after didactic lectures; p=0.003) and to 0.81 (end of training; p<0.0001).
CONCLUSION: Interactive dedicated training significantly improved accuracy in tumour localization and especially in detecting extracapsular extension on prostate MRI.

Entities:  

Mesh:

Year:  2010        PMID: 19921205      PMCID: PMC3609714          DOI: 10.1007/s00330-009-1625-x

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  28 in total

1.  Standardized abnormal interpretation and cancer detection ratios to assess reading volume and reader performance in a breast screening program.

Authors:  L Kan; I A Olivotto; L J Warren Burhenne; E A Sickles; A J Coldman
Journal:  Radiology       Date:  2000-05       Impact factor: 11.105

2.  Subspecialist radiology.

Authors:  S Halligan
Journal:  Clin Radiol       Date:  2002-11       Impact factor: 2.350

3.  Improvement in mammography interpretation skills in a community radiology practice after dedicated teaching courses: 2-year medical audit of 38,633 cases.

Authors:  M N Linver; S B Paster; R D Rosenberg; C R Key; C A Stidley; W V King
Journal:  Radiology       Date:  1992-07       Impact factor: 11.105

Review 4.  The role of MRI and MRSI in diagnosis, treatment selection, and post-treatment follow-up for prostate cancer.

Authors:  Michael Fuchsjäger; Oguz Akin; Amita Shukla-Dave; Darko Pucar; Hedvig Hricak
Journal:  Clin Adv Hematol Oncol       Date:  2009-03

5.  A randomized trial of continuing medical education.

Authors:  J C Sibley; D L Sackett; V Neufeld; B Gerrard; K V Rudnick; W Fraser
Journal:  N Engl J Med       Date:  1982-03-04       Impact factor: 91.245

6.  Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial.

Authors:  M D Rifkin; E A Zerhouni; C A Gatsonis; L E Quint; D M Paushter; J I Epstein; U Hamper; P C Walsh; B J McNeil
Journal:  N Engl J Med       Date:  1990-09-06       Impact factor: 91.245

Review 7.  Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy.

Authors:  Filip G Claus; Hedvig Hricak; Robert R Hattery
Journal:  Radiographics       Date:  2004-10       Impact factor: 5.333

8.  MR imaging in adenocarcinoma of the prostate: interobserver variation and efficacy for determining stage C disease.

Authors:  M L Schiebler; B C Yankaskas; C Tempany; C E Spritzer; M D Rifkin; H M Pollack; P Holtz; E A Zerhouni
Journal:  AJR Am J Roentgenol       Date:  1992-03       Impact factor: 3.959

9.  Prostate cancer: incremental value of endorectal MR imaging findings for prediction of extracapsular extension.

Authors:  Liang Wang; Michael Mullerad; Hui-Ni Chen; Steven C Eberhardt; Michael W Kattan; Peter T Scardino; Hedvig Hricak
Journal:  Radiology       Date:  2004-05-27       Impact factor: 11.105

10.  Prostate cancer: detection of extracapsular extension by genitourinary and general body radiologists at MR imaging.

Authors:  Michael Mullerad; Hedvig Hricak; Liang Wang; Hui-Ni Chen; Michael W Kattan; Peter T Scardino
Journal:  Radiology       Date:  2004-05-27       Impact factor: 11.105

View more
  28 in total

Review 1.  Multiparametric MRI for prostate cancer diagnosis: current status and future directions.

Authors:  Armando Stabile; Francesco Giganti; Andrew B Rosenkrantz; Samir S Taneja; Geert Villeirs; Inderbir S Gill; Clare Allen; Mark Emberton; Caroline M Moore; Veeru Kasivisvanathan
Journal:  Nat Rev Urol       Date:  2019-07-17       Impact factor: 14.432

2.  Performance characteristics of MR imaging in the evaluation of clinically low-risk prostate cancer: a prospective study.

Authors:  Hebert Alberto Vargas; Oguz Akin; Amita Shukla-Dave; Jingbo Zhang; Kristen L Zakian; Junting Zheng; Kent Kanao; Debra A Goldman; Chaya S Moskowitz; Victor E Reuter; James A Eastham; Peter T Scardino; Hedvig Hricak
Journal:  Radiology       Date:  2012-09-05       Impact factor: 11.105

3.  Temporal changes in MRI appearance of the prostate after focal ablation.

Authors:  Andreas M Hötker; Andreas Meier; Yousef Mazaheri; Junting Zheng; Marinela Capanu; Joshua Chaim; Ramon Sosa; Jonathan Coleman; Hedvig Hricak; Oguz Akin
Journal:  Abdom Radiol (NY)       Date:  2019-01

4.  Interobserver Reproducibility of the PI-RADS Version 2 Lexicon: A Multicenter Study of Six Experienced Prostate Radiologists.

Authors:  Andrew B Rosenkrantz; Luke A Ginocchio; Daniel Cornfeld; Adam T Froemming; Rajan T Gupta; Baris Turkbey; Antonio C Westphalen; James S Babb; Daniel J Margolis
Journal:  Radiology       Date:  2016-04-01       Impact factor: 11.105

5.  The incremental value of contrast-enhanced MRI in the detection of biopsy-proven local recurrence of prostate cancer after radical prostatectomy: effect of reader experience.

Authors:  Cecilia Wassberg; Oguz Akin; Hebert Alberto Vargas; Amita Shukla-Dave; Jingbo Zhang; Hedvig Hricak
Journal:  AJR Am J Roentgenol       Date:  2012-08       Impact factor: 3.959

6.  Investigating the ability of multiparametric MRI to exclude significant prostate cancer prior to transperineal biopsy.

Authors:  Eva M Serrao; Tristan Barrett; Karan Wadhwa; Deepak Parashar; Julia Frey; Brendan C Koo; Anne Y Warren; Andrew Doble; Christof Kastner; Ferdia A Gallagher
Journal:  Can Urol Assoc J       Date:  2015-12-14       Impact factor: 1.862

Review 7.  Implementation of Multi-parametric Prostate MRI in Clinical Practice.

Authors:  Andrea S Kierans; Samir S Taneja; Andrew B Rosenkrantz
Journal:  Curr Urol Rep       Date:  2015-08       Impact factor: 3.092

8.  Diagnostic accuracy of a five-point Likert scoring system for magnetic resonance imaging (MRI) evaluated according to results of MRI/ultrasonography image-fusion targeted biopsy of the prostate.

Authors:  Toshitaka Shin; Thomas B Smyth; Osamu Ukimura; Nariman Ahmadi; Andre Luis de Castro Abreu; Chisato Ohe; Masakatsu Oishi; Hiromitsu Mimata; Inderbir S Gill
Journal:  BJU Int       Date:  2017-08-16       Impact factor: 5.588

9.  Detection of prostate cancer with multiparametric MRI (mpMRI): effect of dedicated reader education on accuracy and confidence of index and anterior cancer diagnosis.

Authors:  Kirema Garcia-Reyes; Niccolò M Passoni; Mark L Palmeri; Christopher R Kauffman; Kingshuk Roy Choudhury; Thomas J Polascik; Rajan T Gupta
Journal:  Abdom Imaging       Date:  2015-01

10.  Changes in prostate cancer detection rate of MRI-TRUS fusion vs systematic biopsy over time: evidence of a learning curve.

Authors:  B Calio; A Sidana; D Sugano; S Gaur; A Jain; M Maruf; S Xu; P Yan; J Kruecker; M Merino; P Choyke; B Turkbey; B Wood; P Pinto
Journal:  Prostate Cancer Prostatic Dis       Date:  2017-08-01       Impact factor: 5.554

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.